chrisvoncsefalvay/vaers-outcomes huggingface dataset:
The pt had her first Covid vaccine on 3/28 in the left deltoid.  Within a couple hours, she began to have pain pain in the inner upper left arm, and then later migratory pains that traveled up her legs, across her lower abdominal surgical scar.  She had chills, and fever symptoms.  She developed marked myalgias.  She has photophobia at baseline after her breast cancer chemotherapy, the photophobia is unchanged.  She has chronic neck pain, and she came in wearing a soft cervical collar, but the neck pain is not new.  No known Covid exposure.  She first denied chest pain, but then she pointed to her central sternum and said that she had "bone pain" in the central chest.  She also describes her migratory pain frequently calling it "red" pain.  She denied abdominal pain, but she had a deep central pain deep inside her torso.   Husband was interviewed and he stated that she was in good health before the vaccine.  He did not note the "pale, fatigued, run down" complaint that she reported.  She had the Pfizer vaccine #1 around 1130 hours.  She then began to complain of a discomfort left upper inner arm.  Sunday, 3/28, she began to take advid, first 400mg, then advancing to 800 mg q 4 h, and use of a hot water bottle.  She then began to have the "searing pain" first in the areas where she's had surgery, both breasts and her lower abdomen.  They talked to a RN on 3/30, and then to a tele-MD yesterday when her symptoms worsened, who Rx'd Vicodin.  The husband (and pt) states that the pt gets an upset stomach and "muddled head" when she takes tylenol, and they didn't know that Vicodin had tylenol in it.  Very soon after taking the Vicodin, she began to feel upset stomach and muddled head.  She took two doses of the Vicodin, last dose yesterday.  They spoke with a different tele-MD today, who called in a oxycodone 5mg tab for her, which she took at 1130 hrs and 1500 hours.   Covid Symptom screen ?Cough YES, chronic, no change ?Fever (subjective or >100.4°F/38°C)   YES ?Myalgia  YES ?Headache  YES ?Dyspnea   YES, "sometimes" ?Sore throat   NO ?Diarrhea   NO ?Nausea/vomiting   YES/YES ?Loss of smell or taste  NO , abdominal pain "NO" (pt feels like she is having some discomfort "deep inside" her torso), and rhinorrhea  NO
7 days following  second dose, developed chest pain. Admitted 6/11/2021 with myocarditis -CMR proven. Slowly recovering.
husband / received their Shingrix vaccines 3 yrs ago, late dose; This case was reported by a consumer via call center representative and described the occurrence of incomplete course of vaccination in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received on an unknown date, 3 years before day of reporting).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follow: The case was reported by patient's wife. The patient received his 1st dose 3 years ago. The patient was late for 2nd dose of vaccination. Till the time of reporting, patient did not receive 2nd dose of vaccine which led to incomplete course of vaccination. No further information was provided. This case is linked with US2021083447 reported by same reporter. The reporter did not consent to follow up.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021083447:same reporter (reporter´s case)
Patient received flu shot on 1/9/15 and complained of ongoing arm discomfort to us on 1/20/15.
Diarrhea (1,pt states he has been sick for about 2 weeks. says he has had diarrhea, dry cough, fatigue and weakness.(1) Tested positive for Covid on May 4,2021.
Full body/muscular aches/bruising feeling; shivers. light nausea, Light sensitivity, foggy feeling, light headache, un balanced while standing
Runny nose, chills, muscle aches starting at 10 AM the next day. Worsening injection site pain rated 6/10 the day of vaccination, it hurts more than vaccines I?ve received in the past.
This spontaneous report as received from a pharmacist refers to a 74 years old male patient. The patient had none pertinent medical history. The patient had none drug allergies. On 20-OCT-2012 the patient was vaccinated intramuscularly in right arm with PNEUMOVAX 23 (lot # not reported) from another Pharmacy. Concomitant medications were reported as none. On 21-OCT-2012 the patient developed pain at his right arm pit. Additionally, he developed a dark red, purplish bruise of his entire right forearm and at the crease of his right elbow into his bicep area. The patient sought for medical attention by stopping by at pharmacy. No treatment was given. Lab diagnostics studies performed were reported as none. The outcome was reported as not recovered. Additional information has been requested.
Dizziness and  dry mouth reported. Experiencing Hypertension. EMS called and transported to Hospital ED for treatment.
Irritable, lethargic, marked pallor, shallow respirations, accompanied by fever 104 F & local rxn. 2nd DTP.
Swollen right arm. Pt had red hot rash. Pain to touch. Describes her pain very severe unbearable that she almost went to ER. Rash about 1 1/2 in., felt sick, headache, flu like. Had 2 separate vaccines on different arms the arm where she had PNEUMOVAX she complained.
I was working and started having what I thought was bad indigestion. They did a ECG and said I was having a heart attack double bypass. Two weeks later I had another heart attack, the clot was removed and they put a stent in place. I am now on heart medication and blood thinners.
Had vaccine. Then next day had fever & night sweats. Thursday I had fever with swollen nodes & painful in neck, jaw, arm pit. Then blisters/hives on head, face descending to legs before went to ER. Placed on steroids & given ATARAX for itching.
Information has been received from a registered nurse referring to multiple unspecified patients of unknown age and gender. Pertinent medical history and drug reactions/allergies were not reported. On multiple unspecified dates the patients were administered with doses of improperly stored GARDASIL 9 (lot # L013429, expiration date 21-JUL-2017, dose and route were not reported). Concmitant drug was not reported. This is one of several reports from the same reporter. Additional information has been requested.
Fully vaccinated patient admitted through ED with COVID positive test upon admission.  Admitted 06/28/21 for weakness, confusion, difficulty urinating, and decreased oral intake.  Found to have MSSA bacteremia.  No s/s of COVID throughout stay.
Chills/sweats, didn't have thermometer to take temperature, dizzy/light headed, achiness throughout body, severe headache, fatigue
Vaccine was stored improperly upon arrival to facility. Patient has had no adverse events due to receiving the vaccine.
I developed a liver abscess followed by sepsis. I never suffered from any pre-existing conditions and the cause for the abscess still remains unknown
10/29/2021 evening: Loss of appetite, head & sinus pain.    Overnight and early morning of 10/30:  Nausea, then repeated vomiting.  Also, severe sinus pain which felt like my head would explode.  Also, pulsing, stabbing pains in both ears. 10/30:  No appetite all day, Sinus pain and ear pain, rested and slept all day.   11/1 and 11/2:  Some dizziness, achiness, pale color, sinus congestion, chest pain which hurt in both chest and back to take a deep breath.
Hard, hard breathing. Weakness, chest pains, confusion, coughing (constantly) lasting for 2 months.
Nov 2nd  Shortly after (about five minutes) I received the Pfizer #3 booster shot and post the fifteen-minute waiting period, I experienced a pressure building in the left upper chest area. The pressure continued to increase and became painful with a swelling sensation.  This peaked at about ten minutes and the pressure / pain started to dissipate.  I remained immobile for about fifteen minutes after it completely faded away.  I did not experience any other sign like, nausea, sweating, headache, shortness of breath or pain in my left arm.  I did not have any reoccurring reaction through Nov 7th.
1 hour after: feeling faint and dizzy, pain at injection site 4 hours after:  previous symptoms with additional symptoms: fever (103.7), body aches, chills, horrible headache, fatigue, nausea, increased resting heart rate and non-resting heart rate (see below),  Post-nasal drip, sore throat, congestion, ear ache, increased sweating  All above symptoms lasted for 48 hours. After 48 hours fever and aches subsided , but increased feeling of being hot and increased heart rate continued. Sore throat and post nasal drip also continued. Still persisting today - 8/26/21  Heart rate - before receiving 2nd covid shot, resting heart rate was 40s - 50s bpm, now resting heart rate is in the 70s bpm.  Heart rate is increasing to 120s from very simple activities, like walking across the yard. No history of heart conditions, very healthy, regularly exercise. 5?6? 115lbs   Scheduling a follow up with primary care for increased heart rate on 9/1/21
a sore throat; and congested; experiencing a fever; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (a sore throat), NASAL CONGESTION (and congested) and PYREXIA (experiencing a fever) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced OROPHARYNGEAL PAIN (a sore throat), NASAL CONGESTION (and congested) and PYREXIA (experiencing a fever). At the time of the report, OROPHARYNGEAL PAIN (a sore throat), NASAL CONGESTION (and congested) and PYREXIA (experiencing a fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.        No concomitant medications provided. No treatment information provided.
Pt admitted to hospital, not related to +Covid test.  Only s/s = SOB, SARS test completed for discharge.
About 12 h after vaccination, I got headache, chills, body aches and low fewer which lasted until next day; About 12 h after vaccination, I got headache, chills, body aches and low fewer which lasted until next day; About 12 h after vaccination, I got headache, chills, body aches and low fewer which lasted until next day; About 12 h after vaccination, I got headache, chills, body aches and low fewer which lasted until next day; This is a spontaneous report from a contactable consumer (reported for himself). A 55-years-old male patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot number: unknown) via an unspecified route of administration on 16Feb2021 at 07:45 as SINGLE DOSE (at the age of 55-years) in left arm for covid-19 immunization. Medical history included high cholesterol. The patient had no known allergies. Historical vaccine included: the patient received first dose of bnt162b2 via an unspecified route of administration on 26Jan2021 at 07:30 as SINGLE DOSE (at the age of 55-years) for covid-19 immunization. The patient did not receive any other vaccine in four weeks. Concomitant medications included: atorvastatin (Lipitor), diphenhydramine hydrochloride (Benadryl), Ibuprofen and unspecified multivitamins. Prior to the vaccination the patient was not diagnosed with COVID-19. On 16Feb2021 at 20:00, about 12 hours after vaccination, the patient experienced headache, chills, body aches and low fewer which lasted until next day. It was reported that there was no treatment for events. Since the vaccination the patient had not been tested for COVID-19. The outcome of the events was recovering.
Cellulitis right anterior thigh approx. 7cm around injection site of DTaP. Put on Keflex.
chills; headache; This is a spontaneous report from a contactable Other HCP via Pfizer Sales Representative. This Other HCP reported for a patient of unknown age and gender who received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: unknown) via an unspecified route of administration on an unspecified date as dose 2, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: unknown) via an unspecified route of administration on an unspecified date as dose 1, single for COVID-19 immunization and experienced headache and chills. On an unknown date the patient experience chills and headache. The event outcome was unknown.  No follow-up attempts were possible; information about lot/batch number could not be obtained.
This spontaneous report as received from a pharmacist refers to a male patient of unknown age. On an unknown date the patient was vaccinated with a dose of RECOMBIVAX HB (lot# not reported) (dose and route not reported). The pharmacist reported that the patient had an unspecified reaction to RECOMBIVAX HB (date unspecified, but described as years ago, strength unspecified). The pharmacist reported that the unspecified reaction to RECOMBIVAX HB was due to an allergy to yeast. The outcome was reported as recovered/resolved. Additional information is not expected.
About a week after vaccinations developed a slight fever with malaise. Three days later, ten days after immunization, developed a pruitic rash on trunk (front and back), chest, upper arms, thighs, and peri-area. No treatment given.
Redness, soreness and swelling at injection site. Fever, chills, fatigue. On call doctor prescribed triamcinolone for injection site and rest and ibuprofen for other symptoms.
Patient received Bexsero on 7/6/2020.  On 7/11/2020 patient reports she woke up with severe headache, severe shortness of breath, felt like her throat was closing, and hives at injection site. Patient  then went to the ER  and was treated for severe allergic reaction.  Interestingly, this was her second dose and did not have same reaction to her her first dose.
Pt. states that after receiving the 2nd dose of Phizer 04/22/2021, started experiencing symptoms 06/2021 of constant fatigue, headaches, loose stool, dry coughing, sneezing, and mild irritation. Primary visit 06/2021 Blood Work checked, recommendation for Antibiotics continue use seems to subside the symptoms but expiration of use Symptoms Return. ENT specialist seen with no recommendations.
This spontaneous report as received from a consumer refers to her daughter, a female patient of unknown age. Information regarding relevant medical history and concurrent condition were not reported. In April 2013 the patient was vaccinated with GARDASIL (dose 1, 0.5 ml, route and lot # not reported). In September 2013 the patient was vaccinated with GARDASIL (dose 2, 0.5 ml, route and lot # not reported). The patient had not received a third dose, which should be administered by April 2014 (inappropriate schedule of vaccine administered). No adverse event reported. Additional information is not expected because there is no contact information provided.
Client was vaccinated with the Pfizer Covid vaccine with lot #EW0162 at 11:59am on 04/15/2021. EMT observed client standing at the facility exit speaking to the interpreter.  EMT noted upon approach client appeared alert, tracking with his eyes, in no apparent distress. Client had a chief complaint of numbness at his injection site. Client stated that he had completed his 15 minutes and had exited the site but began to experience numbness at his injection site while exiting. This was the client's first dose of the Pfizer vaccine. Client states he has a history of a deep vein thrombosis and hypertension. Client is not on any medications and denies any known allergies. Assessment revealed that client's left arm/injection site was clean, dry and bandage remained intact. Client was negative for hives, swelling, severe sweating, shortness of breath or other signs of anaphylaxis. Client was alert and oriented to person, place, date, and event; and airway, breathing and circulation were intact. Client had full range of motion of his arm and denied any tingling. Client denied any pain upon palpation of the injection site and stated that his numbness was strictly localized to injection site and did not spread to rest of arm. Client's vital signs upon entering EMT station for further evaluation revealed: blood pressure 180/140, respirations 18, pulse 68, 98% on room air; lung sounds clear bilaterally, temp 98 degrees F, eyes remained equal, round, and reactive to light at 5 mm. Client stated that he had his blood pressure taken last week and that his systolic was approximately 160. Client agreed to remain for an additional 30 minutes of monitoring per site lead nurse and was stable throughout observation. Vital signs at 1220: blood pressure of 180/140, respiratory rate of 18, heart rate of 68, and oxygen saturation of 98% on room air. Vital signs at 1235: blood pressure of 160/124, respiratory rate of 18, heart rate of 76, and oxygen saturation of 99% on room air. Vital signs at 1250: blood pressure of 158/118, respiratory rate of 18, heart rate of 76, and oxygen saturation of 99% on room air. At the completion of the client's observation, client stated that numbness was "better" and stated that it was "almost gone." Client's blood pressure improved upon reassessments, and all other vitals were remained within normal limits. Client was provided with vaccine information packets and encouraged to seek follow-up care or emergency care if symptoms become more severe later in the evening. EMS was denied by client, no medication or other interventions were indicated or administered. Client departed facility by ambulation to private care at 1253 in positive disposition. EMT reported to lead nurse about client's status after client left facility already. Lead nurse educated EMT regarding high blood pressure referral to EMS. But EMT  stated client denied EMS.
This spontaneous report was received from a registered nurse (R.N.) concerning a patient of unknown age and gender. No concurrent conditions or medical history were reported. On 08-SEP-2014, the patient was vaccinated with an improperly stored dose of VAQTA (Lot No. K001792 Expiration date: 22-OCT-2015) (dose, route, anatomical location of administration were not reported). No concomitant therapy was provided. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
FEMALE COMPLAINING OF CHEST PAIN AND TIGHTNESS IN CHEST 10 MINUTES AFTER VACCINATION. ONSITE EMS WAS REQUESTED. SYMPTOMS SUBSIDED AND PATIENT WAS RELEASE BP 169/75   HR 68   OX 100% ON ROOM AIR PATIENT STATES NO PRIOR ADVERSE REACTIONS TO VACCINES. SHE HAD THE INFLUENZA VACCINE ABOUT A MONTH AGO,
Burning scalp after receiving the 1st booster dose; Red scalp after receiving the 1st booster dose; Hair loss after receiving the 1st booster dose/Bald spots after receiving the 1st booster dose; Inappropriate schedule of vaccine administered; This spontaneous case was reported by a patient and describes the occurrence of SKIN BURNING SENSATION (Burning scalp after receiving the 1st booster dose), ERYTHEMA (Red scalp after receiving the 1st booster dose), ALOPECIA (Hair loss after receiving the 1st booster dose/Bald spots after receiving the 1st booster dose) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 066K21A, 024M20A and 032L20A) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (Aspirin) and Drug allergy (simvastatin).   On 27-Jan-2022, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Feb-2022, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 16-May-2022, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 16-May-2022, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered). On 23-May-2022,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced SKIN BURNING SENSATION (Burning scalp after receiving the 1st booster dose), ERYTHEMA (Red scalp after receiving the 1st booster dose) and ALOPECIA (Hair loss after receiving the 1st booster dose/Bald spots after receiving the 1st booster dose). At the time of the report, SKIN BURNING SENSATION (Burning scalp after receiving the 1st booster dose), ERYTHEMA (Red scalp after receiving the 1st booster dose), ALOPECIA (Hair loss after receiving the 1st booster dose/Bald spots after receiving the 1st booster dose) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered) outcome was unknown.            No concomitant medication information was provided.  The caller is a consumer who explains that she received the first dose of the Moderna Covid 19 vaccine on 27Jan2021 and a week after she developed really bad itchy scalp, dry scalp like dandruff and after her hair started coming out. It took her months to grow her hair back. She explained that last month she received the first booster dose of the Moderna Covid 19 vaccine and the symptoms came back, her scalp was burning a lot and it was really red she had been applying sulfate to her hair and she said that for this reason her scalp was not itchy like last time, but she was loosing a lot of hair and said she had bald spots.  Treatment was mentioned as sulfates.   Patient had not tested positive for Covid 19.   This case was linked to MOD-2022-578382 (Patient Link).
Myalgia 2-3 days later left ear started hurting.   Narrative: Oct 6-7 (2-3 days after the vaccine) left ear started hurting. Pain was 2/10. Pain is much less noticeable now. On Monday the 11th woke up with left side of his face paralyzed. Went to see his doctor in his office. He continues to have the paralysis. The doctor diagnosed "a classic case of Bell's Palsy". left  eyelid paresis, left side of mouth drooping, decreased sensation on the left side of is tongue. Hearing has not been affected by sharp sounds (like a dog barking) give him a piercing pain in his left ear. Doctor gave him acyclovir and oral steroid- prednisone. No f/u scheduled.
Pt with mild tingling and itching in her throat approximately 10 minutes after receiving 2nd dose of COVID vaccine. Administered 25 mg PO benadryl with improvement in sx.    Pt again started to develop itching and tingling in her throat. Administered 25 mg PO benadryl. Sx remain the same and then started to worsen after about 10 minutes. Started to feel slightly SOB.  BP 146/92, HR 80.    Rapid response called. Rapid response team at bedside; pt transported to ED for further observation. Pt given 40 mg PO prednisone in the ED. No further ED notes available at this time.    Pt endorses hx of anaphylaxis with her last flu shot. Also had allergic reaction with her first COVID shot including throat tingling and itching that resolved with PO benadryl.